Literature DB >> 26372907

Growth Hormone Receptor Antagonist Transgenic Mice Have Increased Subcutaneous Adipose Tissue Mass, Altered Glucose Homeostasis and No Change in White Adipose Tissue Cellular Senescence.

Ross Comisford1, Ellen R Lubbers, Lara A Householder, Ozan Suer, Tamara Tchkonia, James L Kirkland, Edward O List, John J Kopchick, Darlene E Berryman.   

Abstract

BACKGROUND: Growth hormone (GH)-resistant/deficient mice experience improved glucose homeostasis and substantially increased lifespan. Recent evidence suggests that long-lived GH-resistant/deficient mice are protected from white adipose tissue (WAT) dysfunction, including WAT cellular senescence, impaired adipogenesis and loss of subcutaneous WAT in old age. This preservation of WAT function has been suggested to be a potential mechanism for the extended lifespan of these mice.
OBJECTIVE: The objective of this study was to examine WAT senescence, WAT distribution and glucose homeostasis in dwarf GH receptor antagonist (GHA) transgenic mice, a unique mouse strain having decreased GH action but normal longevity.
METHODS: 18-month-old female GHA mice and wild-type (WT) littermate controls were used. Prior to dissection, body composition, fasting blood glucose as well as glucose and insulin tolerance tests were performed. WAT distribution was determined by weighing four distinct WAT depots at the time of dissection. Cellular senescence in four WAT depots was assessed using senescence-associated β-galactosidase staining to quantify the senescent cell burden, and real-time qPCR to quantify gene expression of senescence markers p16 and IL-6.
RESULTS: GHA mice had a 22% reduction in total body weight, a 33% reduction in lean mass and a 10% increase in body fat percentage compared to WT controls. GHA mice had normal fasting blood glucose and improved insulin sensitivity; however, they exhibited impaired glucose tolerance. Moreover, GHA mice displayed enhanced lipid storage in the inguinal subcutaneous WAT depot (p < 0.05) and a 1.7-fold increase in extra-/intraperitoneal WAT ratio compared to controls (p < 0.05). Measurements of WAT cellular senescence showed no difference between GHA mice and WT controls.
CONCLUSIONS: Similar to other mice with decreased GH action, female GHA mice display reduced age-related lipid redistribution and improved insulin sensitivity, but no change in cellular senescence. The similar abundance of WAT senescent cells in GHA and control mice suggests that any protection against generation of senescent cells afforded by decreased GH action, low insulin-like growth factor 1 and/or improved insulin sensitivity in the GHA mice may be offset by their severe adiposity, since obesity is known to increase senescence.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26372907      PMCID: PMC4760896          DOI: 10.1159/000439050

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  40 in total

1.  Antioxidant enzymes, free-radical damage, and response to paraquat in liver and kidney of long-living growth hormone receptor/binding protein gene-disrupted mice.

Authors:  S J Hauck; J M Aaron; C Wright; J J Kopchick; A Bartke
Journal:  Horm Metab Res       Date:  2002-09       Impact factor: 2.936

Review 2.  Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome.

Authors:  B L Wajchenberg
Journal:  Endocr Rev       Date:  2000-12       Impact factor: 19.871

3.  Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span.

Authors:  Karen T Coschigano; Amy N Holland; Markus E Riders; Edward O List; Allan Flyvbjerg; John J Kopchick
Journal:  Endocrinology       Date:  2003-09       Impact factor: 4.736

4.  High glucose-induced replicative senescence: point of no return and effect of telomerase.

Authors:  Shraga Blazer; Eli Khankin; Yardena Segev; Rachel Ofir; Michal Yalon-Hacohen; Zipora Kra-Oz; Yossi Gottfried; Sarit Larisch; Karl L Skorecki
Journal:  Biochem Biophys Res Commun       Date:  2002-08-09       Impact factor: 3.575

5.  Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003.

Authors:  Zvi Laron
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

6.  Comparing adiposity profiles in three mouse models with altered GH signaling.

Authors:  Darlene E Berryman; Edward O List; Karen T Coschigano; Kevin Behar; Jason K Kim; John J Kopchick
Journal:  Growth Horm IGF Res       Date:  2004-08       Impact factor: 2.372

7.  Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women.

Authors:  Bret H Goodpaster; Shanthi Krishnaswami; Helaine Resnick; David E Kelley; Catherine Haggerty; Tamara B Harris; Ann V Schwartz; Steven Kritchevsky; Anne B Newman
Journal:  Diabetes Care       Date:  2003-02       Impact factor: 19.112

8.  Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice.

Authors:  W Y Chen; M E White; T E Wagner; J J Kopchick
Journal:  Endocrinology       Date:  1991-09       Impact factor: 4.736

9.  Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice.

Authors:  Shoshana Yakar; Jennifer Setser; Hong Zhao; Bethel Stannard; Martin Haluzik; Vaida Glatt; Mary L Bouxsein; John J Kopchick; Derek LeRoith
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

Review 10.  Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity.

Authors:  Allyson K Palmer; Tamara Tchkonia; Nathan K LeBrasseur; Eduardo N Chini; Ming Xu; James L Kirkland
Journal:  Diabetes       Date:  2015-07       Impact factor: 9.461

View more
  5 in total

1.  GH Knockout Mice Have Increased Subcutaneous Adipose Tissue With Decreased Fibrosis and Enhanced Insulin Sensitivity.

Authors:  Edward O List; Darlene E Berryman; Mathew Buchman; Elizabeth A Jensen; Kevin Funk; Silvana Duran-Ortiz; Yanrong Qian; Jonathan A Young; Julie Slyby; Savannah McKenna; John J Kopchick
Journal:  Endocrinology       Date:  2019-07-01       Impact factor: 4.736

Review 2.  Mice with gene alterations in the GH and IGF family.

Authors:  Yanrong Qian; Darlene E Berryman; Reetobrata Basu; Edward O List; Shigeru Okada; Jonathan A Young; Elizabeth A Jensen; Stephen R C Bell; Prateek Kulkarni; Silvana Duran-Ortiz; Patricia Mora-Criollo; Samuel C Mathes; Alison L Brittain; Mat Buchman; Emily Davis; Kevin R Funk; Jolie Bogart; Diego Ibarra; Isaac Mendez-Gibson; Julie Slyby; Joseph Terry; John J Kopchick
Journal:  Pituitary       Date:  2021-11-19       Impact factor: 4.107

3.  Developments in our understanding of the effects of growth hormone on white adipose tissue from mice: implications to the clinic.

Authors:  Darlene E Berryman; Brooke Henry; Rikke Hjortebjerg; Edward O List; John J Kopchick
Journal:  Expert Rev Endocrinol Metab       Date:  2016-02-24

Review 4.  Mouse models of growth hormone insensitivity.

Authors:  Jonathan Young; Stephen Bell; Yanrong Qian; Caroline Hyman; Darlene E Berryman
Journal:  Rev Endocr Metab Disord       Date:  2020-10-10       Impact factor: 6.514

Review 5.  Growth Hormone's Effect on Adipose Tissue: Quality versus Quantity.

Authors:  Darlene E Berryman; Edward O List
Journal:  Int J Mol Sci       Date:  2017-07-26       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.